Tradestie Institutional Equity Comparison Engine
IONS vs BMRN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BMRN Overall Edge
BMRN Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BioMarin Pharmaceuticals Inc (BMRN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, IONS trades at 90.9x Forward P/E with -58.8% operating margin (+54.9% YoY revenue) versus BMRN at 9.1x Forward P/E and 16.3% operating margin (+32.0% YoY). In options structure, IONS sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro) against BMRN sits in CONSOLIDATION (17th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
BMRN
IONS 90.9x vs BMRN 9.1x Fwd P/E
Growth & Margin Winner
BMRN
Op Margin -58.8% vs 16.3% ยท YoY +54.9% vs +32.0%
Momentum & Technical Winner
BMRN
1Y -59.1% vs +7.6% ยท 52W Pos 2% vs 42%
Options & Structure Winner
BMRN
BREAKDOWN (17th %ile IV) vs CONSOLIDATION (17th %ile IV)
IONS
NASDAQ
Ionis Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$28.57
-1.7% 1D
Market Cap
$4.7B
1M Return
-33.48%
1Y Return
-59.1%
Forward P/E
90.9x
Unified AI Score
63.9 / 100
BUY
Tech 60.0
Fund 63.0
Flow 73.0
Mom 55.0
BMRN
NASDAQ
BioMarin Pharmaceuticals Inc
Pharmaceutical Preparations
$58.32
+1.9% 1D
Market Cap
$11.0B
1M Return
+6.66%
1Y Return
+7.56%
Forward P/E
9.1x
Unified AI Score
52.6 / 100
HOLD
Tech 57.0
Fund 61.0
Flow 66.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
IONS -59.1%
BMRN +7.56%
Spread: +66.66 pp (BMRN Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | IONS Revenue | BMRN Revenue | IONS Op. Margin | BMRN Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $600M | $1.49B | -10.2% | -8.3% | BMRN |
| FY2019 | $1.12B | $1.70B | 32.6% | -5.9% | IONS |
| FY2020 | $730M | $1.86B | -23.6% | -2.3% | BMRN |
| FY2021 | $810M | $1.85B | -3.7% | -4.5% | IONS |
| FY2022 | $590M | $2.10B | -69.8% | 7.7% | BMRN |
| FY2023 | $790M | $2.42B | -44.9% | 7.7% | BMRN |
| FY2024 | $710M | $2.85B | -67.4% | 17.0% | BMRN |
| FY2025 | $940M | $3.22B | -40.4% | 12.7% | BMRN |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | IONS | BMRN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $4.7B | $11.0B | Larger Scale | BMRN |
| Trailing P/E Ratio Valuation | 90.9x | 8.8x | Lower Multiple | BMRN |
| Forward P/E Ratio Valuation | 90.9x | 9.1x | Lower Multiple | BMRN |
| Revenue Growth (YoY) Growth | +54.9% | +32.0% | Higher Growth | IONS |
| Operating Margin (TTM) Profitability | -58.8% | 16.3% | Higher Margin | BMRN |
| Net Profit Margin Profitability | -56.9% | -0.5% | Higher Margin | BMRN |
| Return on Equity (ROE) Capital Efficiency | -108.0% | -0.3% | Higher ROE | BMRN |
| 52-Week Range Position Momentum | 2% ($27โ$87) | 42% ($49โ$71) | Stronger Trend | BMRN |
| Beta / 30D Volatility Risk Regime | 0.18ฮฒ ยท 86% Vol | 0.28ฮฒ ยท 31% Vol | Lower Realized Risk | BMRN |
| Unified Institutional Score Composite Signal | 63.9 / 100 (BUY) | 52.6 / 100 (HOLD) | Higher Composite | IONS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full IONS vs BMRN Buy Guide
IONS
BREAKDOWN
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
17th %ile
IV Regime
Compressed (<25th %ile)
BMRN
CONSOLIDATION
67d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
17th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither IONS nor BMRN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.